Alanine
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
310 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hepatitis | D006505 | — | K75.9 | — | 3 | — | 6 | 13 | 22 |
| Hepatitis a | D006506 | EFO_0007305 | B15 | — | 3 | — | 6 | 10 | 19 |
| Hepatitis b | D006509 | — | — | — | 1 | — | 4 | 11 | 16 |
| Chronic hepatitis b | D019694 | EFO_0004239 | B18.1 | — | 1 | — | 4 | 8 | 13 |
| Chronic hepatitis | D006521 | — | K73.9 | — | 1 | — | 4 | 7 | 12 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 1 | 3 | 2 | 1 | 5 | 11 |
| Healthy volunteers/patients | — | — | — | 1 | 2 | — | 1 | 7 | 11 |
| Hepatitis c | D006526 | — | B19.2 | — | 1 | — | 2 | 5 | 8 |
| Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | — | 1 | — | 1 | 4 | 6 |
| Sepsis | D018805 | EFO_0001420 | A41.9 | — | — | 1 | 1 | 4 | 6 |
Show 40 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lymphoma | D008223 | — | C85.9 | 12 | 15 | 1 | — | — | 22 |
| Leukemia | D007938 | — | C95 | 9 | 12 | 1 | — | — | 20 |
| Multiple myeloma | D009101 | — | C90.0 | 7 | 12 | 2 | — | — | 19 |
| Plasma cell neoplasms | D054219 | — | — | 7 | 10 | 2 | — | — | 17 |
| Syndrome | D013577 | — | — | 7 | 6 | 1 | — | 3 | 16 |
| Myelodysplastic syndromes | D009190 | — | D46 | 7 | 7 | 1 | — | — | 14 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 8 | 6 | 1 | — | — | 14 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 6 | 6 | 1 | — | — | 13 |
| Preleukemia | D011289 | — | — | 7 | 5 | 1 | — | — | 12 |
| B-cell lymphoma | D016393 | — | — | 6 | 5 | 1 | — | — | 9 |
Show 25 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Recurrence | D012008 | — | — | 14 | 12 | — | — | — | 18 |
| Liver diseases | D008107 | EFO_0001421 | K70-K77 | 1 | 4 | — | — | 11 | 16 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 10 | 12 | — | — | — | 16 |
| Fatty liver | D005234 | EFO_0003934 | — | — | 6 | — | — | 8 | 14 |
| Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | 6 | — | — | 7 | 13 |
| Myeloid leukemia | D007951 | — | C92 | 8 | 5 | — | — | — | 12 |
| Neoplasms | D009369 | — | C80 | 5 | 6 | — | — | 1 | 11 |
| Myeloproliferative disorders | D009196 | — | D47.1 | 5 | 6 | — | — | — | 11 |
| Lymphoid leukemia | D007945 | — | C91 | 5 | 6 | — | — | — | 10 |
| Hodgkin disease | D006689 | — | C81 | 6 | 7 | — | — | — | 10 |
Show 111 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 1 | — | — | — | 6 | 7 |
| Cognitive dysfunction | D060825 | — | G31.84 | 1 | — | — | — | 3 | 4 |
| Carcinoma | D002277 | — | C80.0 | 2 | — | — | — | — | 2 |
| Hypersensitivity | D006967 | EFO_0003785 | T78.40 | 1 | — | — | — | 1 | 2 |
| Hepatic insufficiency | D048550 | — | — | 1 | — | — | — | 1 | 2 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | — | — | — | 1 | 2 |
| Systemic lupus erythematosus | D008180 | EFO_0002690 | M32 | 1 | — | — | — | 1 | 2 |
| Rhabdoid tumor | D018335 | — | — | 1 | — | — | — | — | 1 |
| Ependymoma | D004806 | — | — | 1 | — | — | — | — | 1 |
| Myeloid sarcoma | D023981 | — | C92.3 | 1 | — | — | — | — | 1 |
Show 17 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | — | — | 7 | 7 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 5 | 5 |
| Diet therapy | D004035 | — | — | — | — | — | — | 4 | 4 |
| Contraception | D003267 | — | — | — | — | — | — | 4 | 4 |
| Hypercholesterolemia | D006937 | — | — | — | — | — | — | 3 | 3 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | — | 3 | 3 |
| Dietary supplements | D019587 | — | — | — | — | — | — | 3 | 3 |
| Fructose intolerance | D005633 | — | E74.12 | — | — | — | — | 3 | 3 |
| Hyperglycemia | D006943 | — | R73.9 | — | — | — | — | 2 | 2 |
| Abdominal obesity | D056128 | — | — | — | — | — | — | 2 | 2 |
Show 125 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 322,514 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
411 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use